Metallothionein-I-II and GFAP positivity in the brains from frontotemporal dementia patients

Journal of Alzheimer's Disease

Volumn 8, Issue 2, 2005, Pages 109-116

  Zatta, P ^a   Zambenedetti, P ^b   Musicco, M ^c   Adorni, F ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b General Hospital   (Italy)

^c INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; METALLOTHIONEIN I; METALLOTHIONEIN II;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; OCCIPITAL CORTEX; OLFACTORY CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 31344462067     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-8203     Document Type: Article

References (32)

1. J. Brown, A. Ashworth, S. Gydesen, S.A. Sorensen, M. Rossor, J. Hardy and J. Collinge, Familial non-specific dementia maps to chromosome 3, Hum. Mol. Genet. 4 (1995), 1625-1628.
2. A. Brun, Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology, Arch Gerontol Geriatr 6 (1987), 193-208.
3. A. Campbell, M.A. Smith, L.M. Sayre, S.C. Bondy and C.G. Perry, Mechanisms by which metals promote events connected to neurodegenerative diseases, Brain Res. Bull. 55 (2001), 125-132.
4. R. Castellani, M.A.Smith, P.L. Richey, R. Kalaria, P. Gambetti and G. Perry, Evidence for oxidative stress in Pick disease and corticobasal degeneration, Brain Res 696 (1995), 268-271.
5. P.N. Cooper, M. Jackson, G. Lennox, J. Lowe and D.M.A. Mann, τ, ubiquitin and αB-crystallin immunocytochemistry define the principle causes of degenerative frontotemporal dementias, Arch. Neurol. 52 (1995), 1011-1015.
6. N.L. Foster, K. Wilhelmsen, A.A.F. Sima, M.Z. Jones, C.J. D'Amato and S. Gilman, Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference, Ann. Neurol. (1997), 706-715.
7. J.L. Gerst, L.S. Siedlak, A. Nunomura, R. Castellani, G. Perry and M.A. Smith, Role of oxidative stress in frontotemporal dementia, Dement. Geriatr. Cogn. Disord. 10(1) (1999), 85-87.
8. B. Halliwell, Reactive oxygen species and the central nervous system, J. Neurochem. 5 (1992), 1609-1623.
9. A.W. Hartzler, X. Zhu, S.L. Siedlak, R.J. Castellani, J. Avila, G. Perry and M.A. Smith, The p38 pathway is activated in Pick disease and progressive supranuclear plasy: A mechanicistic link between mitogenic pathways, oxidative stress, and tau, Neurobiol. Aging 23 (2002), 855-859.
10. J. Hidalgo, M. Aschner, P. Zatta and M. Vašak, Roles of metallothionein family of proteins in the central nervous system, Brain Res. Bull. 55 (2001), 133-146.
11. M. Jackson and J. Lowe, The new neuropathology of neurodegenerative frontotemporal dementia, Acta Neuropathol 91 (1996), 127-134.
12. T. Kawashima, K. Doh-ura, M. Torisu, Y. Uchida, A. Furuta and T. Iwaki, Differential expression of metallothioneins in human prion, Dement. Geriatr. Cogn. Disord. 11 (2000), 251-262.
13. A. Kertesz and G.G. Munoz, eds, Pick's disease and Pick complex, Wiley & Liss, New York, Chichester, 1998.
14. D.S. Knopman, A.R. Mastri, W.H. Frey, J.H. Sung and T. Rustan, Dementia lacking distinctive histological features: a common non-Alzheimer degenerative dementia, Neurology 40 (1990), 251-256.
15. K. Krapfenbauer, E. Engidawork, N. Cairns, M. Fountoulakis and G. Lubec, Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders, Brain Res 967 (2003), 152-160.
16. J. Lowe, Degenerative non-Alzheimer dementias, Brain Pathol 7 (1997), 1047-1051.
17. J. Lowe and M.G. Spillantini, Non-Alzheimer degenerative dementias, Brain Pathol 8 (1998), 295-297.
18. Th. Lüers and H. Spatz, Picksche Krankheit, in: Handbuch der speziellen pathologischen Anatomie und Histologie, Bd XIII/1A, O. Lubarsch, R. Rössle and W. Scholz, eds, Springer, Berlin Göttingen Heidelberg, 1957, pp. 614-715.
19. T. Lynch, M. Sano, K.S. Marder, K.L. Bell, N.L. Foster, R.F. Defendini, A.A.F. Sima, C. Keohane, T.G. Nygaard, S. Falm, R. Mayeux, R.L. Rowland and K.C. Wilhelmsen, Clinical characteristics of a family with chromosome 17-linked disinhibition dementia-parkinsonism-amyotrophy complex, Neurology 44 (1994), 1878-1884.
20. J.E. Natale, J.B. Knight, Y. Cheng, J.E. Rome and V. Gallo, Metallothionein I and II mitigate age-dependent secondary brain injury, J Neurosci Res 78 (2004), 303-314.
21. M. Penkowa, S. Florit, M. Giralt, A. Quintana, A. Molinero, J. Carrasco and J. Hidalgo, Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures, J. Neurosci. Res. 79 (2005), 522-534.
22. P. Poorkaij, T.D. Bird, E. Wijsman, E. Nemens, R.M. Garruto, L. Anderson, A. Andreadis, W.C. Wiederholt, M. Raskind and G.D. Schellenberg, Tau is a candidate gene for chromosome 17 frontotemporal dementia, Ann. Neurol. 43 (1998), 815-825.
23. H.P. Schmitt, Y. Yang and H. Förstl, Frontal lobe degeneration of non-Alzheimer type and Pick's atrophy: lumping or splitting? Eur. Arch. Psychiatr. Clin. Neurosci. 245 (1995), 299-305.
24. E. Schofield, C. Kersaitis, C.E. Shepherd, J.J. Kril and G.M. Halliday, Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau positive glia differentiate those disorders, Brain 126 (2003), 827-840.
25. The Lund and Manchester Groups, Clinical and neuropathological criteria for frontotemporal dementia, J. Neurol. Neurosurg. Psychiar. 57 (1994), 416-418.
26. R. Tissot, J. Costantinidis and J. Richard, La maladie de Pick. Masson, Paris, 1975.
27. M. Van Lockeren, H. Thibodeaux, N. van Bruggen, B. Cairns, R. Gerlai, J.T. Palmer, S.P. Williams and D.G. Lowe, Evidence for a protective role of metallothionein-1 in focal cerebral ischemia, Proc. Natl. Acad. Sci. USA 96(1999), 12870-12875.
28. A.K. West, M.I. Chuah, J.C. Vickers and R.S. Chung, Protective role of metallothioneins in the injured mammalian brain, Rev. Neurosci. 15 (2004), 156-166.
29. K.C. Wilhelmsen, Frontotemporal dementia is on the MAP? Ann. Neurol. 41 (1997), 139-140.
30. Y. Yao, V. Zhukareva, S. Sung, C.M. Clark, J. Rokach, V.M. Lee, J.Q. Tojanowski and D. Pratico, Enhanced brain levels of 8, 12-iso-iPFalpha-VI differentiate AD from frontotemportal dementia, Neurology 61 (2003), 475-478.
31. P. Zambenedetti, R. Giordano and P. Zatta, Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease, J. Chem. Neuroanat. 15 (1998), 21-26.
32. P. Zambenedetti, H.P. Schmitt and P. Zatta, Metallothionein I-II immunohistochemical reactivity in Binswanger's encephalopathy, J. Alzheimer's Dis. 4 (2002), 459-466.